Clinical trials
Phase 3 Sepsis trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Asahi Kasei Pharma America Corporation | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Eisai Inc. | 1 |
| Hellenic Institute for the Study of Sepsis | 1 |
| La Jolla Pharmaceutical Company | 1 |
| Mundipharma Research Limited | 1 |
| Takeda | 1 |
| University of Versailles | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sepsis | 12 |
| Shock, Septic | 4 |
| Systemic Inflammatory Response Syndrome | 3 |
| Candidemia | 2 |
| Candidiasis | 2 |
| Candidiasis, Invasive | 2 |
| Fungemia | 2 |
| Invasive Fungal Infections | 2 |
| Mycoses | 2 |
| Pathologic Processes | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.